Compare SPH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPH | AMPH |
|---|---|---|
| Founded | 1945 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 1996 | 2005 |
| Metric | SPH | AMPH |
|---|---|---|
| Price | $20.34 | $19.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $30.29 |
| AVG Volume (30 Days) | 143.2K | ★ 499.1K |
| Earning Date | 05-07-2026 | 06-01-2026 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | ★ 42.11 | N/A |
| EPS | 0.69 | ★ 2.03 |
| Revenue | ★ $1,432,518,000.00 | $719,887,000.00 |
| Revenue This Year | $2.06 | $7.34 |
| Revenue Next Year | $1.64 | $4.81 |
| P/E Ratio | $29.45 | ★ $9.54 |
| Revenue Growth | ★ 7.94 | N/A |
| 52 Week Low | $17.30 | $18.94 |
| 52 Week High | $21.72 | $31.26 |
| Indicator | SPH | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 25.04 |
| Support Level | $17.86 | N/A |
| Resistance Level | $20.59 | $28.56 |
| Average True Range (ATR) | 0.42 | 1.21 |
| MACD | -0.02 | -0.94 |
| Stochastic Oscillator | 48.93 | 4.13 |
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.